SCHEMBL9314943

SCHEMBL9314943

NCC(CC(=O)O)C1=CNc2ccccc2C=C1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 5/20 0.49
GABBR1 Q9UBS5 5/20 0.49
LMNA P02545 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
NFKB1 P19838 1/20 0.39
DRD3 P35462 1/20 0.39
BLM P54132 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 1/20 0.39
THRB P10828 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 2/20 0.35
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890804 0.67 MAPT (0.41) CYP3A4MEN1TSHRKMT2AGAA
Phenibut SCHEMBL340838 0.67 GABBR2 (1.00) GABBR2GABBR1LMNACYP2C9CYP3A4
Phenibut SCHEMBL9545047 0.67 GABBR2 (1.00) GABBR2GABBR1LMNACYP2C9CYP3A4
Phenibut SCHEMBL351501 0.67 GABBR2 (1.00) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL9594903 0.67 GABBR2 (0.44) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL2723647 0.66 MAPT (0.43) LMNATSHRGAAMAPT
Phenibut SCHEMBL3053795 0.66 GABBR2 (0.96) GABBR2GABBR1LMNACYP2C9CYP3A4
Phenibut SCHEMBL22831453 0.66 GABBR2 (0.96) GABBR2GABBR1LMNACYP2C9CYP3A4
SCHEMBL3997603 0.65 MAPT (0.42) LMNACYP3A4BLMCYP2C19TSHR
SCHEMBL8556258 0.65 MAPT (0.38) LMNATSHRGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed